ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $513,000 | -1.2% | 351,500 | -3.8% | 0.00% | 0.0% |
| Q4 2016 | $519,000 | -16.8% | 365,550 | +2.6% | 0.00% | 0.0% |
| Q3 2016 | $624,000 | +2.1% | 356,420 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $611,000 | -15.6% | 357,280 | -2.7% | 0.00% | -33.3% |
| Q1 2016 | $724,000 | +9.0% | 367,340 | +5.1% | 0.00% | +50.0% |
| Q4 2015 | $664,000 | -0.6% | 349,620 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $668,000 | -58.8% | 349,620 | 0.0% | 0.00% | -66.7% |
| Q2 2015 | $1,622,000 | +6.2% | 349,620 | 0.0% | 0.01% | +20.0% |
| Q1 2015 | $1,528,000 | +47.5% | 349,620 | +17.1% | 0.01% | +25.0% |
| Q4 2014 | $1,036,000 | -13.2% | 298,690 | +4.8% | 0.00% | 0.0% |
| Q3 2014 | $1,194,000 | -3.2% | 284,900 | +35.3% | 0.00% | -20.0% |
| Q2 2014 | $1,234,000 | -5.9% | 210,500 | +1.1% | 0.01% | 0.0% |
| Q1 2014 | $1,312,000 | +11.5% | 208,300 | +3.5% | 0.01% | 0.0% |
| Q4 2013 | $1,177,000 | +115.6% | 201,200 | +94.2% | 0.01% | +150.0% |
| Q3 2013 | $546,000 | +10.1% | 103,600 | +60.9% | 0.00% | 0.0% |
| Q2 2013 | $496,000 | – | 64,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |